ANDRE, Patrick, PhD
To:Pliant Therapeutics Inc., VP, Biology (April)
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
ANDRE, Patrick, PhD
To:Pliant Therapeutics Inc., VP, Biology (April)
Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.
Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.